Please click here to check who's online and chat with them.

Find Verified Diagnostic Kits Suppliers, Manufacturers and Wholesalers

Top Supplier Cities : -   Chennai   Mumbai  
Sep-08-21
Supplier From India
Sep-02-21
Aug-10-21
Supplier From Shoghi Shimla, Himachal Pradesh, India
Aug-07-21
Supplier From India
May-02-23
Supplier From Sarigam, Gujarat, India
1482 Diagnostic Kits Suppliers
Short on time? Let Diagnostic Kits sellers contact you.
Jan-06-23
Supplier From Kadi, Gujarat, India
Oct-03-22
Supplier From Mumbai, Maharashtra, India
Aug-04-22
Supplier From New Delhi, , India
Jul-26-20
Supplier From Noida, Uttar Pradesh, India
 
Anti-SARS-CoV-2 Rapid Test, COVID-19
1. Easier: No special equipment needed, Intuitive visual interpretation.
2. Rapid: Quick sampling by fingertip blood, Results in 10-15min.
3. Accurate: Results with IgG and IgM respectively.
4. Application: as screening tool for potential suspect patients in large numbers.

Testing kit is FDA Emergency Use Authorization (EUA) Approved
Testing kit is CE MARKED-IVD

* Instruction for Use
* Interpretation Guide
* SARS-CoV-2 immunoassays
* Accuracy of the Anti-SARS-CoV-2 Rapid Test Kit
* Anti-SARS Rapid Test Brochure
* COVID-19 Catalog
* EUA Approval Letter
* Fact Sheet for Healthcare Providers
* FDA Letter
* Fact Sheet for Recipients
* FAQ
* CE IVD Notification Certificate

Antibody Performance Measure Estimate of Performance 95% Confidence Interval
IgM Sensitivity (PPA) 95.7% (289/302) (92.8%; 97.5%)
IgM Specificity (NPA) 99.7% (311/312) (98.2%; 99.9%)
IgG Sensitivity (PPA) 99.0% (299/302) (97.1%; 99.7%)
IgG Specificity (NPA) 99.4% (310/312) (97.7%; 99.8%)
Combined Sensitivity (PPA) 99.0% (299/302) (97.1%; 99.7%)
Combined Specificity (NPA) 99% (309/312) (97.2%; 99.7%)
Combined PPV at prevalence = 5% 84.4% (64.6%; 94.6%)
Combined NPV at prevalence = 5% 99.9% (99.8%; 100%)
Testing kit is FDA Emergency Use Authorization (EUA) Approved
Testing kit is CE MARKED-IVD

* Instruction for Use
* Interpretation Guide
* SARS-CoV-2 immunoassays
* Accuracy of the Anti-SARS-CoV-2 Rapid Test Kit
* Anti-SARS Rapid Test Brochure
* COVID-19 Catalog
* EUA Approval Letter
* Fact Sheet for Healthcare Providers
* FDA Letter
* Fact Sheet for Recipients
* FAQ
* CE IVD Notification Certificate
Apr-06-24
Supplier From mumbai, Maharashtra, India
Mar-22-24
Supplier From Hyderabad, Telangana, India
Jan-02-24
Supplier From India
Jul-21-23
Supplier From India
Jun-30-23
Supplier From India
GOLD Member
VERIFIED
Oct-28-24
Supplier From Coimbatore, TN, India
Jun-09-22
 
A rapid in vitro qualitative immunoassay for detection of antibodies to the Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2)

Clear, dependable results in 15 minutes

Requires minimal training and no equipment

So easy it can be used at the lowest levels of health care service

Can use whole blood or serum/plasma

Collection can be by fingerstick or venipuncture

No refrigeration required

Storage conditions 2-30�°C
Jun-09-22
 
COVID-19 Ag Rapid Test Device is an in vitro diagnostic rapidtest for the qualitative detection of antigen (Ag) in humannasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. COVID-19 Ag RapidTest Device is for professional use only and is intended to be used asan aid in the diagnosis of
Jun-09-22
 
COVID-19 serology test.Cellex qSARS-CoV-2 IgG/IgM Rapid Test.qSARS-CoV-2 IgG/IgM Rapid Test Cassette.FDA Grants Emergency Authorization for First Rapid Antibody Test for COVID-19
Jun-25-22
 
CAT No : RCHM-02071. The CareStar COVID-19 Antigen test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within first five days of symptom onset, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.
Oct-10-22
 
Product Details:

Number of Reactions(Preps)/Kit :30T
Brand : SD Biosensor
ICMR Approved : Yes
Result Time (Rapid Kits) : 10 min
CAT No : RK019-30
STANDARD Q HIV 1/2 Ab 3-Line performs qualitative analysis by detecting antibodies specific to HIV-1 (including Group O) and HIV-2 in serum, plasma and whole blood using immunochromatography. With a simple test method, HIV infection status can be discriminated, and with its high sensitivity and specificity, the screening test result can be obtained within 10 minutes.

Easy to use, Easy to read and interpret
Discrimination between HIV-1 and HIV-2 antibodies
Room temperature storage
Performance
Sensitivity : 100% (74/74)/ Specificity : 100% (232/232)
1482 Diagnostic Kits Suppliers
Short on time? Let Diagnostic Kits sellers contact you.